162407pc 01-Dec-2015 Open-Label Study of Test_38797_Val in Sub 01-Dec-2015 Test12209_01

Study identifier:162407pc

ClinicalTrials.gov identifier:NCT02674903

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A Randomized, sdffg01-Dec-2015 Open-Label, 2-Stage Study of INCB047986 Administered Orally to Subjects With Primary Myelodysplastic Syndrome (MDS) Refractory to or Unlikely to Respond to Erythropoiesis-Stimulating Agents (ESAs) 01-Dec-2015

Medical condition

MDS (Myelodysplastic syndrome)

Phase

Phase 1/2

Healthy volunteers

No

Study drug

INCB047986

Sex

All

Actual Enrollment

6

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 31 Jan 2014
Primary Completion Date: 30 Sept 2014
Study Completion Date: 30 Sept 2014

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2026 by Intrasphere

Sponsors

Intrasphere

Collaborators

-

Inclusion and exclusion criteria